uniQure director trades shares, gets new equity awards

uniQure N.V. director Robert Gut reported a mix of equity grants, option exercises, and share sales in Ordinary Shares.

Rhea-AI Filing Summary

uniQure N.V. director Robert Gut reported a mix of equity grants, option exercises, and share sales in Ordinary Shares. On June 10, 2026, he received 7,550 restricted share units at no cost and a stock option for 13,980 shares with a $26.82 exercise price expiring on June 10, 2036. He also exercised options for 2,645 shares at a $16.04 exercise price.

Across June 10–11, 2026, Gut sold 10,278 shares in open‑market transactions at weighted average prices around the mid‑$26 range, including 2,645 shares sold solely to cover estimated withholding taxes upon RSU vesting. The remaining sales were executed under a Rule 10b5‑1 trading plan adopted on July 8, 2025. After these transactions, he directly holds 32,259 Ordinary Shares.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 8 txns

Insider Gut Robert

Role Director

Sold 10,278 shs ($270K)

Approx. gross sale proceeds $270K

Approx. exercise cost $42K

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	2,726	$27.06	$74K
Exercise	Stock Option (Right to Buy)	2,645	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	13,980	$0.00	$0.00
Exercise	Ordinary Shares	2,645	$16.04	$42K
Sale	Ordinary Shares	2,645	$26.07	$69K
Sale	Ordinary Shares	3,127	$26.03	$81K
Sale	Ordinary Shares	1,780	$26.05	$46K
Grant/Award	Ordinary Shares	7,550	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 13,980 contracts (Direct); Ordinary Shares — 32,259 shares (Direct)

Footnotes (9)

1. F1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
2. F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
5. F5. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
6. F6. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
7. F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
8. F8. The Stock Option vested in full on February 24, 2023.
9. F9. The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

Key Figures

Shares sold: 10,278 shares Option exercise size: 2,645 shares Option exercise price: $16.04 per share +5 more

8 metrics

Shares sold 10,278 shares Ordinary Shares sold in open-market transactions on June 10–11, 2026

Option exercise size 2,645 shares Ordinary Shares acquired via option exercise at $16.04 on June 10, 2026

Option exercise price $16.04 per share Exercise price for 2,645-share stock option converted into Ordinary Shares

New RSU grant 7,550 units Restricted share units granted June 10, 2026 under 2014 Share Incentive Plan

New stock option grant 13,980 shares at $26.82 Stock Option (Right to Buy) expiring June 10, 2036

Holdings after transactions 32,259 shares Ordinary Shares directly owned after June 11, 2026 trades

Highest disclosed sale price $27.06 per share Open-market sale of 2,726 Ordinary Shares on June 11, 2026

10b5-1 plan adoption date July 8, 2025 Sales plan governing reported transactions intended to comply with Rule 10b5-1

Key Terms

Rule 10b5-1, restricted share units, withholding taxes, Stock Option (Right to Buy), +1 more

5 terms

Rule 10b5-1 regulatory

"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

restricted share units financial

"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

withholding taxes financial

"shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes"

Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) with 13,980 underlying Ordinary Shares"

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did uniQure (QURE) director Robert Gut report?

Robert Gut reported equity grants, an option exercise, and share sales. He received 7,550 restricted share units, new options for 13,980 shares, exercised options for 2,645 shares, and sold 10,278 Ordinary Shares in several open-market transactions.

How many uniQure (QURE) shares did Robert Gut sell and at what prices?

Gut sold 10,278 Ordinary Shares in multiple open-market trades. Weighted average prices ranged in the mid-$26 area, including one sale at $27.06 per share and others between approximately $26.01 and $26.53, according to the disclosed price ranges.

What equity awards did Robert Gut receive from uniQure (QURE)?

He received 7,550 restricted share units and a stock option covering 13,980 Ordinary Shares. The option has a $26.82 exercise price and expires on June 10, 2036, and both awards vest 100% on the first anniversary of the grant date, subject to continued service.

Were Robert Gut’s uniQure (QURE) share sales pre-planned under Rule 10b5-1?

Yes. The filing states the reported transactions were effected under a sales plan adopted on July 8, 2025, intended to comply with Rule 10b5-1. Such plans pre-schedule trades, so their timing reflects the plan’s terms rather than ad hoc market-timing decisions.

How many uniQure (QURE) shares does Robert Gut hold after these transactions?

After the reported trades, Gut directly holds 32,259 Ordinary Shares. This figure reflects his position following the combination of equity grants, the option exercise for 2,645 shares, and total sales of 10,278 shares over June 10–11, 2026.

Were any of Robert Gut’s uniQure (QURE) share sales for tax withholding?

Yes. The filing explains that some shares were sold upon vesting of restricted share units solely to cover estimated withholding taxes. These sales followed automatic sale instructions in the RSU agreement and were not discretionary trades by Gut.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 06:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gut Robert

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM 1105BP

(City) (State) (Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/10/2026		M(1)		2,645	A	$16.04	34,987	D
Ordinary Shares	06/10/2026		S(1)		2,645	D	$26.07(2)	32,342	D
Ordinary Shares	06/10/2026		S(1)		3,127	D	$26.03(3)	29,215	D
Ordinary Shares	06/10/2026		S(1)		1,780	D	$26.05(4)	27,435	D
Ordinary Shares	06/10/2026		A		7,550(5)	A	$0	34,985	D
Ordinary Shares	06/11/2026		S(6)		2,726(6)	D	$27.06(7)	32,259	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$16.04	06/10/2026		M(1)			2,645	(8)	02/24/2032	Ordinary Shares	2,645	$0	0	D
Stock Option (Right to Buy)	$26.82	06/10/2026		A		13,980		(9)	06/10/2036	Ordinary Shares	13,980	$0	13,980	D

Explanation of Responses:

1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

5. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

6. The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

8. The Stock Option vested in full on February 24, 2023.

9. The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.

	/s/ Christian Klemt, Attorney-in-Fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)